{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:40:11Z","timestamp":1787312411686,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72670-y","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T11:02:14Z","timestamp":1727434934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical characteristics and long-term treatment outcomes of polypoidal choroidal vasculopathy with classic type leakage"],"prefix":"10.1038","volume":"14","author":[{"given":"Jae Hui","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Gu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"72670_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","volume":"10","author":"LA Yannuzzi","year":"1990","unstructured":"Yannuzzi, L. A., Sorenson, J., Spaide, R. F. & Lipson, B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina10, 1\u20138 (1990).","journal-title":"Retina"},{"key":"72670_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","volume":"15","author":"RF Spaide","year":"1995","unstructured":"Spaide, R. F., Yannuzzi, L. A., Slakter, J. S., Sorenson, J. & Orlach, D. A. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina15, 100\u2013110 (1995).","journal-title":"Retina"},{"key":"72670_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/ceo.13114","volume":"46","author":"KK Dansingani","year":"2018","unstructured":"Dansingani, K. K., Gal-Or, O., Sadda, S. R., Yannuzzi, L. A. & Freund, K. B. Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of \u2018expanded Spectra\u2019 - a review. Clin. Exp. Ophthalmol.46, 189\u2013200 (2018).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"72670_CR4","first-page":"454","volume":"110","author":"T Otsuji","year":"2006","unstructured":"Otsuji, T. et al. Evaluation of cases of polypoidal choroidal vasculopathy showing classic choroidal neovascularization in their natural course. Nippon Ganka Gakkai Zasshi110, 454\u2013461 (2006).","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"72670_CR5","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1136\/bjo.2006.112318","volume":"91","author":"H Tamura","year":"2007","unstructured":"Tamura, H. et al. Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography. Br. J. Ophthalmol.91, 1152\u20131159 (2007).","journal-title":"Br. J. Ophthalmol."},{"key":"72670_CR6","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1136\/bjophthalmol-2017-311518","volume":"102","author":"S Liang","year":"2018","unstructured":"Liang, S., Shi, X., Rosenfeld, P. J. & Li, X. Type 2 choroidal neovascularisation in polypoidal choroidal vasculopathy: a retrospective case series. Br. J. Ophthalmol.102, 1570\u20131574 (2018).","journal-title":"Br. J. Ophthalmol."},{"key":"72670_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/IAE.0000000000003264","volume":"42","author":"T Izumi","year":"2022","unstructured":"Izumi, T., Koizumi, H., Maruko, I., Hasegawa, T. & Iida, T. Optical coherence tomography angiography findings of classic choroidal neovascularization in polypoidal choroidal vasculopathy. Retina42, 123\u2013128 (2022).","journal-title":"Retina"},{"key":"72670_CR8","first-page":"2437","volume":"260","author":"KB Freund","year":"2022","unstructured":"Freund, K. B. et al. Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR. Graefes Arch. Clin. Exp. Ophthalmol.260, 2437\u20132447 (2022).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"72670_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/08820538.2022.2131438","volume":"38","author":"JH Kim","year":"2023","unstructured":"Kim, J. H., Kim, J. W. & Kim, C. G. Difference in lesion reactivation between pure type 2 and mixed type 1 and 2 macular neovascularization and its influence on long-term treatment outcomes. Semin Ophthalmol.38, 358\u2013364 (2023).","journal-title":"Semin Ophthalmol."},{"key":"72670_CR10","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1167\/iovs.15-16494","volume":"56","author":"B Chae","year":"2015","unstructured":"Chae, B. et al. Baseline predictors for good versus poor visual outcomes in the treatment of neovascular age-related macular degeneration with intravitreal anti-VEGF therapy. Invest. Ophthalmol. Vis. Sci.56, 5040\u20135047 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"72670_CR11","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/jcm4071380","volume":"4","author":"S Mrejen","year":"2015","unstructured":"Mrejen, S. et al. Long-term visual outcomes for a treat and extend anti-vascular endothelial growth factor regimen in eyes with neovascular age-related macular degeneration. J. Clin. Med.4, 1380\u20131402 (2015).","journal-title":"J. Clin. Med."},{"key":"72670_CR12","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","volume":"136","author":"WK Lee","year":"2018","unstructured":"Lee, W. K. et al. Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial. JAMA Ophthalmol.136, 786\u2013793 (2018).","journal-title":"JAMA Ophthalmol."},{"key":"72670_CR13","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1007\/s00417-023-06144-8","volume":"261","author":"JH Kim","year":"2023","unstructured":"Kim, J. H., Kim, J. W. & Kim, C. G. Influence of lesion location on lesion reactivation after initial treatment in neovascular age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol.261, 3139\u20133148 (2023).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"72670_CR14","doi-asserted-by":"publisher","first-page":"22546","DOI":"10.1038\/s41598-022-25860-5","volume":"12","author":"JH Kim","year":"2022","unstructured":"Kim, J. H., Kim, J. W. & Kim, C. G. Comparison of 24-month treatment outcomes between as-needed treatment and switching to treat-and-extend in type 3 macular neovascularization. Sci. Rep.12, 22546 (2022).","journal-title":"Sci. Rep."},{"key":"72670_CR15","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/archopht.1991.01080090066027","volume":"109","author":"Macular Photocoagulation Study Group","year":"1991","unstructured":"Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. guidelines for evaluation and treatment in the macular photocoagulation study. Arch. Ophthalmol.109, 1242\u20131257 (1991).","journal-title":"Arch. Ophthalmol."},{"key":"72670_CR16","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","volume":"121","author":"E Daniel","year":"2014","unstructured":"Daniel, E. et al. Risk of scar in the comparison of age-related macular degeneration treatments trials. Ophthalmology121, 656\u2013666 (2014).","journal-title":"Ophthalmology"},{"key":"72670_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ajo.2020.02.016","volume":"214","author":"EH Souied","year":"2020","unstructured":"Souied, E. H. et al. Spectral-domain optical coherence tomography analysis of fibrotic lesions in neovascular age-related macular degeneration. Am. J. Ophthalmol.214, 151\u2013171 (2020).","journal-title":"Am. J. Ophthalmol."},{"key":"72670_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10384-003-0057-4","volume":"48","author":"M Nakajima","year":"2004","unstructured":"Nakajima, M., Yuzawa, M., Shimada, H. & Mori, R. Correlation between indocyanine green angiographic findings and histopathology of polypoidal choroidal vasculopathy. Jpn J. Ophthalmol.48, 249\u2013255 (2004).","journal-title":"Jpn J. Ophthalmol."},{"key":"72670_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1442-9071.2004.00827.x","volume":"32","author":"S Kuroiwa","year":"2004","unstructured":"Kuroiwa, S., Tateiwa, H., Hisatomi, T., Ishibashi, T. & Yoshimura, N. Pathological features of surgically excised polypoidal choroidal vasculopathy membranes. Clin. Exp. Ophthalmol.32, 297\u2013302 (2004).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"72670_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/bjo.86.3.321","volume":"86","author":"H Terasaki","year":"2002","unstructured":"Terasaki, H., Miyake, Y., Suzuki, T., Nakamura, M. & Nagasaka, T. Polypoidal choroidal vasculopathy treated with macular translocation: Clinical pathological correlation. Br. J. Ophthalmol.86, 321\u2013327 (2002).","journal-title":"Br. J. Ophthalmol."},{"key":"72670_CR21","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1007\/s00417-021-05525-1","volume":"260","author":"G Liu","year":"2022","unstructured":"Liu, G. et al. Clinicopathological study of the polypoidal lesions of polypoidal choroidal vasculopathy. Graefes Arch. Clin. Exp. Ophthalmol.260, 2369\u20132377 (2022).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"72670_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00006982-199414020-00007","volume":"14","author":"MW MacCumber","year":"1994","unstructured":"MacCumber, M. W. et al. Clinicopathologic correlation of the multiple recurrent serosanguineous retinal pigment epithelial detachments syndrome. Retina14, 143\u2013152 (1994).","journal-title":"Retina"},{"key":"72670_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10792-012-9681-7","volume":"33","author":"DI Sia","year":"2013","unstructured":"Sia, D. I., Ebneter, A., Sinkar, S. & Gilhotra, J. Polypoidal choroidal vasculopathy: naked polyp. Int. Ophthalmol.33, 67\u201369 (2013).","journal-title":"Int. Ophthalmol."},{"key":"72670_CR24","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","volume":"32","author":"A Koh","year":"2012","unstructured":"Koh, A. et al. EVEREST study: Efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina32, 1453\u20131464 (2012).","journal-title":"Retina"},{"key":"72670_CR25","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1097\/IAE.0000000000001845","volume":"38","author":"JH Kim","year":"2018","unstructured":"Kim, J. H. et al. Morphologic features associated with fibrotic scarring after anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy. Retina38, 2168\u20132176 (2018).","journal-title":"Retina"},{"key":"72670_CR26","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.ophtha.2018.01.004","volume":"125","author":"E Daniel","year":"2018","unstructured":"Daniel, E. et al. Development and course of scars in the comparison of age-related macular degeneration treatments trials. Ophthalmology125, 1037\u20131046 (2018).","journal-title":"Ophthalmology"},{"key":"72670_CR27","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1167\/iovs.15-17279","volume":"56","author":"Y Niwa","year":"2015","unstructured":"Niwa, Y., Kakinoki, M., Sawada, T., Wang, X. & Ohji, M. Ranibizumab and aflibercept: Intraocular pharmacokinetics and their effects on aqueous VEGF level in vitrectomized and nonvitrectomized macaque eyes. Invest. Ophthalmol. Vis. Sci.56, 6501\u20136505 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"72670_CR28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/bjo.2007.116160","volume":"91","author":"T Iida","year":"2007","unstructured":"Iida, T. Polypoidal choroidal vasculopathy with an appearance similar to classic choroidal neovascularisation on fluorescein angiography. Br. J. Ophthalmol.91, 1103\u20131104 (2007).","journal-title":"Br. J. Ophthalmol."},{"key":"72670_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/jop.2016.0098","volume":"33","author":"JH Kim","year":"2017","unstructured":"Kim, J. H., Chang, Y. S., Lee, D. W., Kim, C. G. & Kim, J. W. Incidence and timing of the first recurrence in neovascular age-related macular degeneration: Comparison between ranibizumab and aflibercept. J. Ocul Pharmacol. Ther.33, 445\u2013451 (2017).","journal-title":"J. Ocul Pharmacol. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72670-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72670-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72670-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T11:13:51Z","timestamp":1727435631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72670-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72670"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72670-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"29 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22346"}}